Medika
Financiado
Commercialisation of dental medical device for measuring salivary pH
Oral hygiene is very important for health and well-being of humans. The global market of home dental hygiene products is more than 30 billion USD world-wide, with an estimated increase of 8% annually (CAGR). Several recent studies...
Oral hygiene is very important for health and well-being of humans. The global market of home dental hygiene products is more than 30 billion USD world-wide, with an estimated increase of 8% annually (CAGR). Several recent studies have proved that salivary pH is a diagnostic biomarker of oral and even some gastroenterological diseases. The deviation of salivary pH from the normal value of 7.2 indicates pathological status. However, the self-measurement of salivary pH is very difficult, even impossible, since no device is commercialised for this purpose. Salivary pH is now usually measured from spittle using pH indicator paper (lacmus). This measurement is not accurate enough, and difficult to carry out by patients at home. We have developed and designed an easy-to use medical device for measuring the salivary pH in the mouth. The new device is revolutionary ergonomic, have data storage and transfer capabilities, connection to smart devices, accurate (0.1 pH), ball-pan-sized and accessible for visually impaired (Braille writing). We have protected the design and participated in several start-up events, where we won different local awards. Medika device is ground-breaking, creating new market, as it will be the first self-measurement device for measuring salivary pH at home. It will help dentists to measure and record the pH of saliva for large number of patients routinely and remotely before and after dental surgery. Its use by the wide public will prevent or avoid worsening of several oral and gastroenterological diseases. The aim of this phase 1 project is to make a feasibility study for both the technical and business development actions planned for the commercialisation of Medika device: to specify the software and the prototype, to prepare for clinical validation, to refine our business plan and to prepare the project plan for an SME Instrument Phase 2 application.
ver más
Duración del proyecto: 6 meses
Fecha Inicio: 2018-07-13
Fecha Fin: 2019-01-31
Fecha Fin: 2019-01-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2019-01-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
MEDIKA PRO KORLATOLT FELELOSSEGU TARSASAG
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
458.89K€ |
Participante